rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CPHI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Breakingviews - COMMENTARY: China emerges as obesity drug lab for Big Pharma
      Nov 11ReutersCPHI
      China’s rapid human trials draw western drugmakers — and safety concerns
      Oct 23Financial TimesCPHI
      Biotech investment is the new front in the U.S.-China trade fight
      Oct 22PoliticoCPHI
      China’s drugmakers move into the big league
      Oct 21Financial TimesCPHI
      China’s pharmaceutical stocks gain favour amid ‘greater’ progress in innovation

      The nation’s innovative drug out-licensing deals reached US$130 billion by the end of September, almost matching 2025’s full-year level.

      Oct 21South China Morning PostCPHI
      China’s pharma stocks gain favours amid ‘greater’ progress of innovative drugs

      The nation’s innovative drug out-licensing deals reached US$130 billion by the end of September, almost matching 2025’s full-year level.

      Oct 21South China Morning PostCPHI
      12 Health Care Stocks Moving In Wednesday's After-Market Session
      Oct 7BenzingaVALNCPHI
      China's InnoCare, Eli Lilly sign collaboration deal worth up to $3.35 billion
      Sep 24ReutersCPHI
      European drugmakers call for faster trials, more spending to compete with US, China
      Sep 22ReutersSNYCPHI
      Pharmaceutical Companies Push Trump Administration to Protect China Deals
      Sep 21WSJCPHI
      U.S. weighs allowing most pharma licensing deals with China

      The U.S. is drafting rules for biopharma firms investing in China that would likely maintain their ability to ink most licensing deals for Chinese drugs. Read more here.

      Sep 18Seeking AlphaCPHI
      EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
      Sep 18ReutersCPHI
      The West is hooked on Chinese drugs but they could save your life
      Sep 17The TelegraphCPHI
      Shares Climb As China Pharma Services Billionaire Faces Fine
      Sep 14ForbesCPHI
      China's Huawei eyes more AI partnerships in China’s pharma sector - report (KWEB:NYSEARCA)
      Aug 27Seeking AlphaCPHIKWEB

      This is the newest page. Registered accounts read further back.